Notably, with the exception of PALB2,6 the breast cancer risk for these more recently described genes is substantially lower than for BRCA1 and BRCA2 and they are commonly described as moderate risk genes (risks twofold to fourfold compared with the population). The gene discussed is BRCA2; the disease is breast cancer.